期刊文献+

自体富血小板凝胶联合负压引流治疗老年糖尿病足的临床探讨 被引量:12

Clinical Study on Autologous Platelet-rich Gel and Negative Pressure Drainage in Treatment of Senile Diabetic Foot
下载PDF
导出
摘要 目的探讨自体富血小板凝胶联合负压引流治疗老年糖尿病足的临床效果。方法随机选取2012年7月—2016年8月该院治疗的老年糖尿病足60例,按入院顺序编号1~60,并按奇偶数分组,奇数组为观察组,采用自体富血小板凝胶联合负压引流治疗,偶数组为对照组,采用常规外科治疗方法,观察治疗效果并进行安全性评价。结果观察组愈合80.0%,对照组愈合40.0%,对照组平均愈合时间为(15.2±4.1)d,观察组为(10.4±1.2)d,组间比较(P<0.05)。对照组4例发生创口感染,不良反应发生率为26.7%,观察组无不良反应,组间比较,差异有统计学意义(P<0.05)。结论针对老年糖尿病足患者采用自体富血小板凝胶联合负压引流治疗,能够快速控制感染,促进溃疡愈合,极大的缩短伤口愈合时间,且应用安全,不仅为患者解除了痛苦,也缓解了患者的经济负担,是一种临床值得推广的方法。 Objective To discuss the clinical effect of autologous platelet-rich gel and negative pressure drainage in treatment of senile diabetic foot.Methods 60 cases of senile patients with diabetic foot treated in our hospital from July 2012 to August 2016 were random selected and divided into two groups according to the admission order,the observation group adopted the autologous platelet-rich gel and negative pressure drainage treatment,while the control group adopted the routine surgical treatment method,and the treatment effect was observed and the safety was evaluated.Results The differences in the healing rate,average healing time an incidence rate of adverse reactions between the observation group and the control group had statistical significance(P〈0.05)[80.0%,(15.2±4.1)d,26.7% vs 40.0%,(10.4±1.2)d,0.0%],and in the control group,there were 4 cases with wound infection.Conclusion The autologous platelet-rich gel and negative pressure drainage in treatment of senile diabetic foot can rapidly control infection,promote the ulcer healing,greatly shorten the wound healing time,and the application is safe,which can not only help patients relieve pains,but also relieve the economic burden of patients,and it is worth clinical promotion.
作者 孙正刚
出处 《中外医疗》 2017年第7期55-57,共3页 China & Foreign Medical Treatment
关键词 自体富血小板凝胶 负压引流 老年糖尿病足 Autologous platelet-rich gel Negative pressure drainage Senile diabetic foot
  • 相关文献

参考文献8

二级参考文献89

  • 1冯扬,唐休发.富血小板血浆在颌面部非血管化骨移植中的应用[J].中国修复重建外科杂志,2006,20(9):944-946. 被引量:7
  • 2Dohan DM,Choukroun J,Diss A,et al.Platelet-rich fibrin(PRF):a sec-ond-generation platelet concentrate.Part II:platelet-related biologic fea-tures[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006;101(3):45-50. 被引量:1
  • 3Dohan DM,Choukroun J,Diss A,et al.Platelet-rich fibrin(PRF):a sec-ond-generation platelet concentrate.Part III:leucocyte activation:a new feature for platelet concentrates?[J].Oral Surg Oral Med Oral Pathol O-ral Radiol Endod,2006;101(3):51-5. 被引量:1
  • 4Dohan DM,Choukroun J,Diss A,et al.Platelet-rich fibrin(PRF):a sec-ond-generation platelet concentrate.Part I:technological concepts and e-volution[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2006;101(3):37-44. 被引量:1
  • 5He L,Lin Y,Hu X,et al.A comparative study of platelet-rich fibrin(PRF)and platelet-rich plasma(PRP)on the effect of proliferation and differentiation of rat osteoblasts in vitro[J].Oral Surg Oral Med Oral Pathol Oral Radiol Endod,2009;108(5):707-13. 被引量:1
  • 6Dohan-Ehrenfest DM,de Peppo GM,Doglioli P,et al.Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin(PRF):a gold standard to achieve for all surgical platelet concentrates technologies[J].Growth Factors,2009;27(1):63-9. 被引量:1
  • 7Dohan Ehrenfest DM,Doglioli P,de Peppo GM,et al.Choukroun's plate-let-rich fibrin(PRF)stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way[J].Arch Oral Biol,2010;55(3):185-94. 被引量:1
  • 8Dohan-Ehrenfest DM,Del Corso M,Diss A,et al.Three-dimensional ar-chitecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane[J].J Periodontol,2010;81(4):546-55. 被引量:1
  • 9Broderick E,Infanger S,Turner TM,et al.Depressed bone mineralization following high dose TGF-beta1 application in an orthopedic implant mod-e(lJ).Calcif Tissue Int,2005;76(5):379-84. 被引量:1
  • 10Chang IC,Tsai CH,Chang YC.Platelet-rich fibrin modulates the expres-sion of extracellular signal-regulated protein kinase and osteoprotegerin in human osteoblasts[J].J Biomed Mater Res A,2010;95(1):327-32. 被引量:1

共引文献89

同被引文献113

引证文献12

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部